Canagliflozin vs Trastuzumab Deruxtecan

Canagliflozin vs Trastuzumab Deruxtecan: Overview

This comparison examines the pharmacological differences between Canagliflozin and Trastuzumab Deruxtecan.

Mechanism of Action

Canagliflozin: Selective SGLT2 inhibitor reducing renal glucose reabsorption and lowering blood glucose.

Pharmacokinetics

Half-life: Canagliflozin — 10.6 hours.

Chemical Properties

Molecular Formula: Canagliflozin — C24H25FO5S.

Molecular Weight: Canagliflozin — 444.5170 g/mol.

Type: Canagliflozin — Small molecule; Trastuzumab Deruxtecan — Antibody drug conjugate.